Fujifilm Sonosite to Investigate Role of Point-of-Care Ultrasound in COVID-19 Patients Through Clinical Research
By HospiMedica International staff writers Posted on 16 Sep 2020 |
Image: Fujifilm Sonosite to Investigate Role of Point-of-Care Ultrasound in COVID-19 Patients Through Clinical Research (Photo courtesy of FUJIFILM Sonosite, Inc.)
FUJIFILM Sonosite, Inc. (Bothell, WA, USA) and the CHEST Foundation, the charitable foundation of the American College of Chest Physicians (Glenview, IL, USA), have announced their joint grant in creating the CHEST Foundation Research Grant in Ultrasonography and COVID-19.
Although early studies report that point-of-care ultrasound (POCUS) is providing numerous benefits to intensive care clinicians caring for COVID-19 patients, additional research on the efficacy in the management of this deadly virus is critical. The objective of the grant is to investigate the role of POCUS technology on COVID-19 patients through clinical research. FUJIFILM Sonosite is contributing up to two grants of USD 30,000 to the CHEST Foundation in support of the joint program and will also donate its newly-launched Sonosite PX ultrasound systems to the selected research award sites.
"COVID-19 continues to negatively affect the health of people around the globe and overwhelm health care systems," said Diku Mandavia, Senior Vice President, Chief Medical Officer of FUJIFILM Sonosite. "As a company that is focused on providing innovative, point of care ultrasound technology to healthcare providers, we're excited to host a joint grant with the CHEST Foundation. This research grant will investigate how POCUS can help in COVID-19 ICU care and has the potential to build upon the current evidence."
"As the pandemic continues to sweep the world, our goal is to help accelerate research efforts including the role of imaging modality innovations in the diagnosis and management of patients with COVID-19," said CHEST Foundation President Edward J. Diamond.
Although early studies report that point-of-care ultrasound (POCUS) is providing numerous benefits to intensive care clinicians caring for COVID-19 patients, additional research on the efficacy in the management of this deadly virus is critical. The objective of the grant is to investigate the role of POCUS technology on COVID-19 patients through clinical research. FUJIFILM Sonosite is contributing up to two grants of USD 30,000 to the CHEST Foundation in support of the joint program and will also donate its newly-launched Sonosite PX ultrasound systems to the selected research award sites.
"COVID-19 continues to negatively affect the health of people around the globe and overwhelm health care systems," said Diku Mandavia, Senior Vice President, Chief Medical Officer of FUJIFILM Sonosite. "As a company that is focused on providing innovative, point of care ultrasound technology to healthcare providers, we're excited to host a joint grant with the CHEST Foundation. This research grant will investigate how POCUS can help in COVID-19 ICU care and has the potential to build upon the current evidence."
"As the pandemic continues to sweep the world, our goal is to help accelerate research efforts including the role of imaging modality innovations in the diagnosis and management of patients with COVID-19," said CHEST Foundation President Edward J. Diamond.
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans